ZITROMAX

This brand name is authorized in Brazil, Ecuador, Italy, Spain, Tunisia, Turkey.

Active ingredients

The drug ZITROMAX contains one active pharmaceutical ingredient (API):

1	Azithromycin UNII 5FD1131I7S - AZITHROMYCIN DIHYDRATE
	Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation.
	Read more about Azithromycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FA10	Azithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	522717080056417, 522717080056517, 522717080056617, 522717080056717, 522717080056817, 522717080056917, 522717080057017, 522717080057117, 522717080057217, 522717080057317
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	19.917-2-10-11, 367680913
ES	Centro de información online de medicamentos de la AEMPS	59615, 59616, 59620, 60065, 60066, 61272, 64834
IT	Agenzia del Farmaco	027860028, 027860042
TN	Direction de la Pharmacie et du Médicament	8013021, 8013022
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308091024, 8681308281005, 8681308281012, 8681308281036